WHEN ICONS COLLIDE: DOS EQUIS® ADDS A NEW CHAPTER TO THE MYTH OF THE MOST INTERESTING MAN IN THE WORLD® WITH FUERZA REGIDA | June 2026
WHEN ICONS COLLIDE: DOS EQUIS® ADDS A NEW CHAPTER TO THE MYTH OF THE MOST INTERESTING MAN IN THE WORLD® WITH FUERZA REGIDA Jun 15, 2026
VERTANICAL Receives First European Marketing Authorization for Exilby® as a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain - Pivotal U.S. Phase 3 trial underway Jun 09, 2026